The Office of Foreign Assets Control of the US Department of the Treasury has designated Goldpharma Drug Trafficking and Money Laundering Organization as a significant foreign narcotics trafficker pursuant to the Foreign Narcotics Kingpin Designation Act, 21 USC §1901 et seq., along with eight individuals associated with the on-line pharmacy organization in Argentina, and nine entities in Argentina, Columbia, Canada, the United Kingdom and the Netherlands.
According to OFAC, Goldpharma is based in Argentina, and operates a global network of on-line pharmacy websites that sell legitimate medications and illegally produced and sold narcotics to customers in the United States. The designated individuals operate entities, designated by OFAC as well, that help launder the proceeds of Goldpharma sales. Five of the individuals have been indicted in the United States District Court for the Eastern District of Wisconsin for their participation in Goldpharma activities.
As a result of these designations, US property owned or controlled by the designated parties will be blocked. Pursuant to the designations, seven US companies controlled by Goldpharma have been blocked, including two Delaware, three Texas, and two Florida companies. Four condominiums in Florida connected with one of the blocked entities have also been blocked.